Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

International Stem Cell (ISCO) Change in Inventory (2016 - 2025)

International Stem Cell (ISCO) has disclosed Change in Inventory for 16 consecutive years, with -$12000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Change in Inventory rose 82.61% to -$12000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $238000.0, a 155.91% increase, with the full-year FY2024 number at -$114000.0, down 200.0% from a year prior.
  • Change in Inventory was -$12000.0 for Q3 2025 at International Stem Cell, down from $300000.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $300000.0 in Q2 2025 to a low of -$220000.0 in Q4 2024.
  • A 5-year average of $36210.5 and a median of $40000.0 in 2024 define the central range for Change in Inventory.
  • Peak YoY movement for Change in Inventory: surged 687.5% in 2023, then plummeted 1592.31% in 2024.
  • International Stem Cell's Change in Inventory stood at $52000.0 in 2021, then plummeted by 319.23% to -$114000.0 in 2022, then surged by 88.6% to -$13000.0 in 2023, then tumbled by 1592.31% to -$220000.0 in 2024, then skyrocketed by 94.55% to -$12000.0 in 2025.
  • Per Business Quant, the three most recent readings for ISCO's Change in Inventory are -$12000.0 (Q3 2025), $300000.0 (Q2 2025), and $170000.0 (Q1 2025).